Join Us

Stewardship

All our posts in one place

HLC response to Senate Finance Committee Democrats’ RFI on Drug Pricing

HLC urged Congress to preserve incentives for continued biopharmaceutical innovation while pursuing solutions that improve affordability for beneficiaries. The letter raised concerns about proposals to expand Medicare drug price negotiation and impose additional pricing controls, while supporting efforts to strengthen Medicare Part D market stability, expand access to Low-Income Subsidy benefits, and improve uptake of existing affordability programs.

August 17, 2026 No Comments

HLC and Confidentiality Coalition response to the White House Office of Science and Technology Policy “Regulatory Reform for Artificial Intelligence” RFI

The Healthcare Leadership Council (HLC) and the Confidentiality Coalition respond to the White House Office of Science and Technology Policy’s Request for Information on regulatory reform for artificial intelligence (AI). Their central message: Create a unified, risk-based federal AI policy that preempts conflicting state laws and enables innovation in healthcare.

October 29, 2025 No Comments

HLC and Confidentiality Coalition Response to RFI on AI

The Healthcare Leadership Council (HLC) and the Confidentiality Coalition provide formal comments to the National Science Foundation and NITRD in response to a Request for Information on developing a national AI Action Plan. Their goal is to ensure federal policy supports innovation in healthcare AI while avoiding burdensome or conflicting regulations.

March 15, 2025 No Comments

Confidentiality Coalition letter to HHS Office of Civil Rights on HIPAA Civil Monetary Penalties and Recognized Security Practices RFI

In this letter to HHS OCR, the Confidentiality Coalition responds to an RFI on implementing two HITECH Act provisions. It asks OCR to give regulated entities credit for the recognized security practices they have in place, using a sliding scale of reduced enforcement, and to limit payouts to harmed individuals to clear economic harm so OCR can prioritize its cybersecurity work.

June 6, 2022 No Comments

Confidentiality Coalition letter to House Energy & Commerce Committee on consumer protection hearing

In this letter to House Energy and Commerce leaders, the Confidentiality Coalition urges HIPAA-aligned privacy protections for health data collected outside HIPAA, partially due to the surge in data collected during COVID-19. It encourages the FTC to examine health data protections and Congress to pass national privacy legislation, with patient consent required for sharing and limits on use beyond the consented purpose.

July 27, 2021 No Comments

Confidentiality Coalition letter to CMS on provider burden/prior authorization rule

The Healthcare Leadership Council and the Confidentiality Coalition submitted comments on the proposed HTI-5 Rule, supporting efforts to reduce unnecessary regulatory burdens while ensuring that patient privacy and data security remain protected. They urged ASTP/ONC to preserve strong confidentiality safeguards and avoid policy changes that could weaken trust in the secure exchange and use of health information. Overall, the letter advocates for a balanced approach that promotes healthcare innovation, interoperability, and administrative simplification without compromising protections for sensitive patient data.

January 1, 2021 No Comments